Minneapolis, MN, United States of America

Birte Aggeler


Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator in Biotech: The Contributions of Birte Aggeler

Introduction: Birte Aggeler, a prominent inventor based in Minneapolis, MN, is making significant strides in the field of biotechnology. With a solid portfolio of three patents, her contributions focus on the advancement of monoclonal antibodies and their applications, showcasing her dedication to innovation in the scientific community.

Latest Patents: Birte's latest patents include groundbreaking work on hybridoma clones and monoclonal antibodies targeted at VSIG-4. These patents detail how her monoclonal antibodies bind to VSIG-4, effectively blocking its interaction with SIGLEC-7, alongside methods for their production and application. Another key patent involves compounds that modulate the interaction of VISTA and VSIG3, which includes processes for creating both polyclonal and monoclonal antibodies. This work emphasizes methods to influence the interaction of VISTA with VSIG3 through the introduction of modulating compounds.

Career Highlights: Birte has established herself at Bio-Techne Corporation, where her work is centered on the development of innovative solutions in biotechnology. Her research has opened new avenues for therapeutic applications, highlighting her role as a forward-thinking inventor who is constantly pushing the boundaries of science.

Collaborations: In her professional environment, Birte collaborates with notable colleagues such as Christine Goetz and Jody Bonnevier. These partnerships enhance the potential for developing novel technologies and foster a collaborative spirit within the biotech community.

Conclusion: Birte Aggeler's contributions to the field of biotechnology through her patents and collaborative efforts mark her as an influential figure. Her innovative work continues to advance the understanding and application of monoclonal antibodies, paving the way for future breakthroughs in medical science. As a dedicated inventor, she exemplifies the spirit of innovation that drives progress in healthcare and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…